IPO Advisory
In-depth, experienced and seamless execution throughout the IPO Process.
IPO Detail
IPO Information
Financial
Financial Report
Peer Comparison
Performance
Performance Report
Earum Pharmaceuticals IPO listing price is ₹ 36.05, issue price is ₹ 36.00, and currently trading at ₹ 1.17 as on June 11, 2025. Earum Pharmaceuticals IPO performance is show below with latest CAGR.
*CAGR is calculated basis issue price at the time of IPO and Current Market Price without taking into Consideration Bonus/Right issue.
*Stock splits/Reverse Stock Split are adjusted in Issue price while calculating CAGR and current performance.
Earum Pharmaceuticals IPO is a Fixed Price listing on BSE SME exchange. The company is based in Ahmedabad and caters to Pharmaceutical sector. Hem Securities is the merchant banker of Earum Pharmaceuticals IPO. It is a SME IPO which filed its Draft Red Herring Prospectus (DRHP) on 9th April 2019.
Earum Pharmaceuticals IPO offer price is ₹ 36.00 and got listed at ₹ 36.05. Read Earum Pharmaceuticals IPO details mentioned above.The IPO of Earum Pharmaceuticals Limited was listed on 4th July 2019. As of today, Earum Pharmaceuticals IPO is trading at ₹ 1.17, compared to the previous day’s close of ₹ 2.46. Read the report above for detailed IPO performance.
The issue price of Earum Pharmaceuticals IPO was ₹ 36.00 per equity share.
Earum Pharmaceuticals IPO was listed at ₹36.05 on the stock exchange on 4th July 2019. The listing price is the price at which the shares started trading on the stock exchange after the IPO was completed.
As of June 11, 2025, the current market price of Earum Pharmaceuticals IPO is ₹ 1.17.
The 52-week high for Earum Pharmaceuticals IPO is [●], while the 52-week low is [●]. These figures reflect the stock’s highest and lowest trading prices in the past one year from the current date.
The Earum Pharmaceuticals IPO listed at ₹ 36.05 against the issue price of ₹ 36.00 per equity share, showing a listing day gain/loss of 0.049999999999997 (0.14%) , calculated by comparing the listing price to the issue price on the first day of trading.
The Earum Pharmaceuticals IPO stock moved from its listing price of ₹ 36.05 to the current price of ₹1.17 per equity share, reflecting a change of -96.75% per share, calculated by subtracting the listing price from the current market price (CMP) as of today.
Based on Earum Pharmaceuticals IPO issue date of 4th July 2019 and CMP of ₹1.17, the estimated CAGR is approximately -43.76%.
*CAGR is calculated basis issue price at the time of IPO and Current Market Price without taking into Consideration Bonus/Right issue.
*Stock splits/Reverse Stock Split are adjusted in Issue price while calculating CAGR and current performance.
Face
Value :
₹ 10
Issue
Price :
₹ 36.00
Listing Price :
₹ 36.05
Previous Day Closing
₹ 2.46
Earum Pharmaceuticals IPO may offer opportunites, depending on your investment strategy. For in-depth analysis, risk factors, and KPIs, check our detailed report on Earum Pharmaceuticals Financial Review Page
Merchant Banker(s) of Earum Pharmaceuticals IPO: Hem Securities Limited
Earum Pharmaceuticals IPO subscription was 1.60 X. IPO subscription refers to applications received in an IPO by each quota, i.e., QIB, Retail, and NII. In some IPOs, Eligible employee quota and shareholder’s quota are also present. Learn more about IPO subscriptions here.
Earum Pharmaceuticals IPO listed at a listing price of 36.05 against the offer price of 36.00.
The current market price of Earum Pharmaceuticals is 1.17.
Why Us?
